a-Helical Corticotropin Releasing Factor (12-41) Reference: HY-P3683 a-Helical Corticotropin Releasing Factor (12-41) is a 30 amino acids long, α-helical analogue of corticotropin releasing factor/hormone. Corticotropin releasing factor (CRF) is a hypothalamic hormone, which stimulates the secretion of adrenocorticotrophic hormone (ACTH). a-Helical Corticotropin Releasing Factor (12-41) would suppress the stimulatory effect.
iRGD peptide Reference: HY-P0122 iRGD peptide is a 9-amino acid cyclic peptide, triggers tissue penetration of agents by first binding to av integrins, then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties.
D-Ala-Gly-Phe-Met-NH2 Reference: HY-P3555 D-Ala-Gly-Phe-Met-NH2, an opioid peptide, is a potent opiate δ-receptor agonist.
Fmoc-Phe(3-Me)-OH Reference: HY-W013152 Fmoc-Phe(3-Me)-OH is a Fmoc-protected phenylalanine derivative.
PG106 TFA Reference: HY-P1209A PG106 TFA is a potent and selective human melanocortin 3 (hMC3) receptor antagonist (IC50= 210 nM) and has noactivity at hMC4 receptors (EC50=9900 nM) and hMC5 receptor.
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide Reference: HY-P3616 Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide is a biotin labeled glucagon-like peptide-1-(7-36). Glucagon-like peptide-1-(7-36) is a gastrointestinal peptide with antidiabetogenic activity, and can increase the release of insulin.